$6.62
-0.33-4.75%
At close: Nov 13, 4:00 PM EST
$6.96
0.345.14%
After Hours: Nov 13, 7:32 AM EST

The average analyst price target for Kazia Therapeutics is $27.10, 289.4% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $15 to $40. The latest change came on Oct 30, 2026, when Needham initiated coverage of Kazia Therapeutics with a Buy rating and a $27 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months